Results 71 to 80 of about 409 (138)

Expanding the therapeutic horizons of spesolimab: a review of off-label applications for inflammatory skin diseases

Journal of Dermatological Treatment
Purpose This review aims to outline the crucial role of IL-36 signaling in inflammatory skin diseases and summarize the therapeutic potential of spesolimab.
Hanlin Zhang, Jia Zhou, Keyun Tang, Xinyi Zhang, Hongzhong Jin   +4 more
doaj   +1 more source

Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option? [PDF]

Dermatol Ther, 2022
Megna M, Potestio L, Di Caprio N, Tajani A, Fabbrocini G, Annunziata A.   +5 more
europepmc   +1 more source

Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled

Frontiers in Medicine
IntroductionPustular psoriasis is considered a separate entity from plaque psoriasis and can be categorized as generalized pustular psoriasis (GPP), acrodermatitis continua of Hallopeau, or palmoplantar pustulosis (PPP). Current guidelines mostly include
Giulia Coscarella, Giulia Coscarella, Gennaro Marco Falco, Gennaro Marco Falco, Gerardo Palmisano, Gerardo Palmisano, Elena Ippoliti, Elena Ippoliti, Eleonora De Luca, Eleonora De Luca, Niccolò Gori, Niccolò Gori, Lucia Di Nardo, Giacomo Caldarola, Clara De Simone, Clara De Simone, Andrea Chiricozzi, Andrea Chiricozzi, Ketty Peris, Ketty Peris   +19 more
doaj   +1 more source

Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report. [PDF]

Dermatol Ther, 2022
Battista T, Guerrasio G, De Fata Salvatores G, Peduto T, Fabbrocini G, Di Guida A.   +5 more
europepmc   +1 more source

A unique combination of Generalised Pustular Psoriasis (GPP), Acrodermatitis Continua of Hallopeau (ACH), and psoriatic arthritis (both axial and peripheral) in a young male – a case-based review of literature

Egyptian Rheumatology and Rehabilitation
Background The simultaneous occurrence of generalised pustular psoriasis (GPP), acrodermatitis continua of Hallopeau (ACH), and Psoriatic arthritis (PsA) in the same patient is infrequently documented in the literature.
Ritasman Baisya, Sukdev Manna, Sneha Dhali   +2 more
doaj   +1 more source

Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau. [PDF]

Skin Appendage Disord, 2022
Rizzetto G, Diotallevi F, Molinelli E, Radi G, Offidani AM.   +4 more
europepmc   +1 more source

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort. [PDF]

J Eur Acad Dermatol Venereol, 2022
Assan F, Husson B, Hegazy S, Seneschal J, Aubin F, Mahé E, Jullien D, Sbidian E, D'Incan M, Conrad C, Brenaut E, Girard C, Richard MA, Bachelez H, Viguier M, “Groupe de Recherche sur le Psoriasis” de la Société Française de Dermatologie.   +15 more
europepmc   +1 more source

Acrodermatitis continua of Hallopeau [PDF]

, 2020
openaire   +1 more source

Treatment of Acrodermatitis Continua of Hallopeau With Ustekinumab as Monotherapy [PDF]

JAMA Dermatology, 2016
Rachel M, Cymerman, David E, Cohen
openaire   +2 more sources

Vunakizumab for Treatment of Acrodermatitis Continua of Hallopeau: A Case Report and Literature Review. [PDF]

Psoriasis (Auckl)
Yao Y, Ma Y, Zhong H, Guo F, Zhu J, Wu Y, Tang S.   +6 more
europepmc   +1 more source